BPC-157 Dosage Guide Subcutaneous Research & Applications

BPC-157 dosage guide subcutaneous is the primary low-KD keyword focus for this updated guide. PrimeBodySolution supports researchers in the United States with research grade, high purity, COA verified peptide sourcing language and relevant internal links.

how to reconstitute peptides step by step is a priority low-KD topic for researchers in the United States comparing research grade, high purity, COA verified peptide suppliers. This guide is for educational research use only and links to relevant PrimeBodySolution product pages where appropriate.

BPC-157, or Body Protection Compound-157, is one of the most extensively studied synthetic peptides in modern research. This BPC-157 dosage guide provides researchers with a comprehensive overview of published study protocols, reconstitution methods, and research applications based on peer-reviewed literature. Whether you are new to peptide research or looking to refine your experimental protocols, this guide covers everything you need to know about BPC-157.

Disclaimer: This article is for educational and research purposes only. BPC-157 we sell as a research chemical and is not approved for human use by the FDA. The information presented here is based on published scientific studies and is not intended as medical advice.

What Is BPC-157?

BPC-157 is a synthetic pentadecapeptide — a chain of 15 amino acids — derived from a protective protein found in human gastric juice. Its amino acid sequence is GEPPPGKPADDAGLV, with a molecular weight of approximately 1419.53 g/mol. The peptide was first isolated and characterized by researchers studying the protective mechanisms of gastric secretions, and it has since become one of the most widely investigated peptides in preclinical research.

The “BPC” designation stands for “Body Protection Compound,” reflecting the peptide’s observed protective properties in numerous animal studies. Unlike many synthetic peptides, BPC-157 demonstrates remarkable stability in gastric juice, which has made it a subject of particular interest for researchers studying gastrointestinal healing and tissue repair mechanisms.

BPC-157 Research Applications

Published research on BPC-157 spans multiple areas of investigation. The following sections summarize key findings from peer-reviewed studies:

Tissue Repair and Wound Healing Research

Multiple animal studies have demonstrated BPC-157’s effects on tissue repair processes. Research published in the Journal of Physiology-Paris (Sikiric et al., 2014) documented accelerated healing of various tissue types in rodent models, including muscle, tendon, ligament, and bone tissue. The peptide appears to promote angiogenesis (new blood vessel formation) and modulate growth factor expression, particularly VEGF (Vascular Endothelial Growth Factor).

Gastrointestinal Research

Given its origin from gastric juice proteins, BPC-157 has been extensively studied in gastrointestinal models. Research has shown protective effects against various forms of experimentally induced gastrointestinal damage in animal models, including ulcers, inflammatory bowel conditions, and esophageal damage (Sikiric et al., 2016).

Musculoskeletal Research

Studies in rodent models have investigated BPC-157’s effects on tendon healing, with research published in the Journal of Orthopaedic Research showing accelerated recovery of transected Achilles tendons in rats (Chang et al., 2011). Additional studies have examined its effects on muscle healing and bone fracture repair.

Neuroprotective Research

Emerging research has explored BPC-157’s potential neuroprotective properties. Animal studies have investigated its effects on peripheral nerve damage, with some studies reporting improved functional recovery following nerve crush injuries (Gjurasin et al., 2010).

Nitric Oxide System Interaction

Research suggests that BPC-157 interacts with the nitric oxide (NO) system, which plays a crucial role in vascular function, inflammation, and tissue repair. Studies have shown that BPC-157 can modulate NO synthesis pathways, which may partially explain its observed effects on blood vessel formation and tissue healing (Sikiric et al., 2018).

BPC-157 Dosage in Published Research Studies

Understanding the dosage protocols used in published research is essential for designing rigorous experiments. The following table summarizes dosage ranges from peer-reviewed animal studies:

Study Type	Animal Model	Dosage Range	Administration Route	Duration
Tendon healing	Rat	10 mcg/kg/day	Intraperitoneal (IP)	14-28 days
Gastric ulcer	Rat	10 mcg/kg/day	IP or oral	7-14 days
Muscle healing	Rat	10 mcg/kg/day	IP or local	14-72 days
Nerve repair	Rat	10 mcg/kg/day	IP	14-28 days
Bone healing	Rabbit	10 mcg/kg/day	Local application	28 days
Inflammatory bowel	Rat	10-50 mcg/kg/day	IP or oral	7-14 days

Key observation: The most commonly used dosage across published BPC-157 research is 10 mcg/kg/day administered intraperitoneally. Some studies have used higher doses (up to 50 mcg/kg) or different routes of administration depending on the research question.

BPC-157 Reconstitution for Research

Proper reconstitution is critical for maintaining peptide integrity in your experiments. For a detailed step-by-step process, see our complete guide on how to reconstitute peptides.

Standard BPC-157 Reconstitution Protocol

1. Allow the lyophilized BPC-157 vial to reach room temperature (15-20 minutes)
2. Sterilize the vial stopper with an alcohol swab
3. Draw the desired volume of bacteriostatic water into a sterile syringe
4. Inject the water slowly along the inside wall of the vial
5. Gently swirl until fully dissolved (typically 1-2 minutes)
6. Store reconstituted solution at 2-8°C

Common BPC-157 Reconstitution Volumes

Vial Size	BAC Water Added	Concentration	Volume per 250mcg
5mg	2.0 mL	2.5 mg/mL	0.10 mL (10 units)
5mg	2.5 mL	2.0 mg/mL	0.125 mL (12.5 units)
10mg	2.0 mL	5.0 mg/mL	0.05 mL (5 units)
10mg	5.0 mL	2.0 mg/mL	0.125 mL (12.5 units)

BPC-157 Storage Guidelines

Proper storage is essential for maintaining BPC-157 stability and ensuring consistent research results:

• Lyophilized (unreconstituted): Store at -20°C for long-term storage or 2-8°C for up to 90 days
• Reconstituted with BAC water: Store at 2-8°C and use within 28 days
• Reconstituted with sterile water: Use within 24 hours or freeze in aliquots
• Avoid: Repeated freeze-thaw cycles, direct sunlight, and temperatures above 25°C

For comprehensive storage protocols, read our guide on peptide storage best practices for research labs.

BPC-157 Mechanism of Action: Current Understanding

While the exact mechanism of action is still being elucidated, published research suggests several pathways through which BPC-157 exerts its effects:

1. VEGF upregulation — BPC-157 appears to increase expression of vascular endothelial growth factor, promoting new blood vessel formation at injury sites
2. Nitric oxide modulation — The peptide interacts with the NO system, influencing vascular tone and inflammatory responses
3. Growth factor signaling — Research suggests BPC-157 may modulate EGF, FGF, and other growth factor pathways involved in tissue repair
4. FAK-paxillin pathway — Studies indicate involvement in focal adhesion kinase signaling, which is critical for cell migration and wound healing
5. Dopaminergic system interaction — Some research has shown effects on dopamine system regulation

Quality Considerations for BPC-157 Research

The quality of your BPC-157 directly impacts the reliability of your research results. When sourcing BPC-157 for research, consider these factors:

• Purity verification: Look for HPLC purity ≥98%, ideally ≥99%. Review the Certificate of Analysis carefully.
• Mass spectrometry confirmation: The CoA should include MS data confirming the correct molecular weight (1419.53 g/mol for BPC-157 free acid)
• Amino acid analysis: Verifies the correct amino acid composition and ratios
• Endotoxin testing: Important for in vivo research applications
• Supplier reputation: Choose suppliers with transparent testing documentation. Prime Body Solutions provides comprehensive third-party testing data with every peptide order.

BPC-157 vs Other Research Peptides

Researchers often compare BPC-157 with other peptides studied for similar applications:

Feature	BPC-157	TB-500	GHK-Cu
Origin	Gastric juice protein	Thymosin Beta-4 fragment	Human plasma tripeptide
Amino acids	15	43	3 (+ copper ion)
Primary research focus	GI protection, tissue repair	Cell migration, tissue repair	Skin remodeling, wound healing
Oral stability	High (gastric juice stable)	Low	Low
Published studies	100+	50+	70+

Browse our full selection of research peptides to find the compounds you need for your studies.

Frequently Asked Questions

What is the most common BPC-157 dosage used in research?

The most frequently cited dosage in published animal studies is 10 mcg/kg/day, administered intraperitoneally. Some studies have used doses ranging from 10-50 mcg/kg depending on the research model and objectives.

How should BPC-157 be stored before reconstitution?

Lyophilized BPC-157 you should store at -20°C for long-term storage. It can be kept at 2-8°C (refrigerated) for up to 90 days. Always protect from light and moisture.

Is BPC-157 stable in solution?

When reconstituted with bacteriostatic water and stored at 2-8°C, BPC-157 remains stable for approximately 28 days. For longer storage, freeze aliquots at -20°C.

What solvent should I use to reconstitute BPC-157?

Bacteriostatic water is the recommended solvent for BPC-157 reconstitution. The peptide is highly soluble in aqueous solutions and does not typically require acidic or organic solvents.

How do I verify the quality of my BPC-157?

Request and review the Certificate of Analysis (CoA) from your supplier. Look for HPLC purity ≥98%, mass spectrometry confirmation of the correct molecular weight, and ideally endotoxin testing results. Learn more in our guide on how to verify peptide purity certificates.

Where can I purchase research-grade BPC-157?

Prime Body Solutions offers HPLC-tested BPC-157 with verified 99%+ purity, complete with third-party Certificates of Analysis and fast US shipping.

References

• Sikiric, P., et al. (2014). “Brain-gut axis and pentadecapeptide BPC 157: Theoretical and practical implications.” Current Neuropharmacology, 14(8), 857-865.
• Chang, C.H., et al. (2011). “The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration.” Journal of Applied Physiology, 110(3), 774-780.
• Sikiric, P., et al. (2018). “Stable gastric pentadecapeptide BPC 157 and wound healing.” Frontiers in Pharmacology, 9, 1446.
• Gjurasin, M., et al. (2010). “Peptide therapy with pentadecapeptide BPC 157 in traumatic nerve injury.” Regulatory Peptides, 160(1-3), 33-41.